Related Experiment Video
Updated: Dec 24, 2025

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
MCPH1 Lack of Function Enhances Mitotic Cell Sensitivity Caused by Catalytic Inhibitors of Topo II
María Arroyo1, Antonio Sánchez1, Ana Cañuelo1
1Department of Experimental Biology, University of Jaén, 23071 Jaén, Spain.
Abstract:
The capacity of Topoisomerase II (Topo II) to remove DNA catenations that arise after replication is essential to ensure faithful chromosome segregation. Topo II activity is monitored during G2 by a specific checkpoint pathway that delays entry into mitosis until the chromosomes are properly decatenated. Recently, we demonstrated that the mitotic defects that are characteristic of cells depleted of MCPH1 function, a protein mutated in primary microcephaly, are not a consequence of a weakened G2 decatenation checkpoint response. However, the mitotic defects could be accounted for by a minor defect in the activity of Topo II during G2/M. To test this hypothesis, we have tracked at live single cell resolution the dynamics of mitosis in MCPH1 depleted HeLa cells upon catalytic inhibition of Topo II. Our analyses demonstrate that neither chromosome alignment nor segregation are more susceptible to minor perturbation in decatenation in MCPH1 deficient cells, as compared with control cells. Interestingly, MCPH1 depleted cells were more prone to mitotic cell death when decatenation was perturbed. Furthermore, when the G2 arrest that was induced by catalytic inhibition of Topo II was abrogated by Chk1 inhibition, the incidence of mitotic cell death was also increased. Taken together, our data suggest that the MCPH1 lack of function increases mitotic cell hypersensitivity to the catalytic inhibition of Topo II.
Insights
MCPH1 depletion increases cell death when Topoisomerase II (Topo II) activity is inhibited. Cells lacking MCPH1 function show heightened sensitivity to Topo II catalytic inhibition, leading to increased mitotic cell death.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- Topoisomerase II (Topo II) is crucial for resolving DNA catenations, ensuring accurate chromosome segregation during mitosis.
- A G2 checkpoint monitors Topo II activity to prevent mitotic entry until decatenation is complete.
- MCPH1 protein, mutated in primary microcephaly, is implicated in mitotic regulation, but its role in Topo II function was unclear.
Purpose of the Study:
- To investigate whether MCPH1 deficiency impacts Topo II activity or sensitivity during mitosis.
- To determine if MCPH1-depleted cells exhibit altered responses to Topo II catalytic inhibition.
- To elucidate the role of MCPH1 in maintaining mitotic fidelity under Topo II stress.
Main Methods:
- Live single-cell imaging of MCPH1-depleted HeLa cells undergoing mitosis.
- Catalytic inhibition of Topoisomerase II (Topo II) to perturb DNA decatenation.
- Assessment of chromosome alignment and segregation dynamics.
- Analysis of mitotic cell death incidence and G2 arrest abrogation via Chk1 inhibition.
Main Results:
- MCPH1-deficient cells did not show increased susceptibility to minor decatenation defects in chromosome alignment or segregation.
- MCPH1-depleted cells exhibited a higher incidence of mitotic cell death when Topo II activity was catalytically inhibited.
- Abrogation of the Topo II-induced G2 arrest by Chk1 inhibition further increased mitotic cell death in MCPH1-deficient cells.
Conclusions:
- MCPH1 deficiency does not impair the G2 decatenation checkpoint but increases mitotic hypersensitivity to Topo II catalytic inhibition.
- The absence of MCPH1 function sensitizes cells to Topo II activity perturbations, leading to elevated mitotic cell death.
- MCPH1 plays a critical role in cellular resilience against Topo II-mediated mitotic stress.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Drugs that Destabilize Microtubules
Inhibition of Cdk Activity
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

